Agricultural Biotechnology Coordination Act
- Sponsor
- Sen. Padilla, Alex [D-CA]
- Committees
- Agriculture, Nutrition, and Forestry Committee (primary)
- Last action
- Sep 3, 2025
Bottom line
The bill aims to centralize and elevate biotechnology policy within the USDA to foster innovation, streamline regulatory processes, and ensure coordinated federal engagement with agricultural biotechnology and related emerging technologies.
What it actually does
This bill amends the Department of Agriculture Reorganization Act of 1994 to mandate the establishment of an Office of Biotechnology Policy within the Department of Agriculture (USDA). This new office is tasked with prioritizing biotechnology, coordinating related policies and activities across the USDA, and leading interagency coordination with other federal and state agencies, while also consulting with stakeholders.
Proponents argue
Supporters argue that establishing a dedicated Office of Biotechnology Policy is crucial for the United States to maintain global leadership in agricultural innovation. They contend it will streamline regulatory processes, enhance research and development coordination, improve communication with stakeholders, and ensure a coherent federal strategy for biotechnology, ultimately benefiting farmers, consumers, and the economy.
Opponents contend
Critics might argue that creating a new office could add unnecessary bureaucracy and potentially duplicate efforts already being undertaken by existing USDA agencies or interagency working groups. They may contend that current structures are sufficient for coordination and that a new office might lead to an overemphasis on biotechnology at the expense of other important agricultural research and development areas.
The bill is very short and its provisions are straightforward, making it highly accessible for a quick read and easy comprehension.
Section 2
Establishment of the Office of Biotechnology Policy
This section amends the Department of Agriculture Reorganization Act of 1994 by inserting a new section 223, which mandates the creation of an 'Office of Biotechnology Policy' within the Department of Agriculture. This Office, headed by a Director reporting directly to the Secretary, will be responsible for prioritizing and coordinating all USDA policies and activities related to biotechnology, biomanufacturing, synthetic biology, and emerging technologies. Its duties include overseeing research, communication, regulation, commercialization, and trade aspects, assisting other USDA offices, leading interagency coordination with bodies like the EPA and FDA, and consulting with external stakeholders.
Supporters argue
Supporters argue that this office is crucial for the USDA to effectively manage and promote the rapidly evolving field of biotechnology, ensuring the U.S. remains competitive and benefits from innovations in agriculture. It will provide a single point of contact and expertise, reducing fragmentation and improving efficiency in policy development and regulatory oversight.
Critics contend
Some might argue that creating a new office adds bureaucracy and could duplicate efforts already handled by existing departments or interagency working groups. They might contend that a more agile, less formal coordination mechanism would be more effective than establishing a permanent, dedicated office.
Tradeoffs
The bill seeks to balance the need for focused leadership and strategic prioritization in biotechnology with concerns about creating new bureaucratic structures. It aims to streamline processes and improve coordination but introduces a new administrative layer that will require careful management to avoid redundancy.